Immediate Impact
53 standout
Citing Papers
Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Works of Stefanie Morris being referenced
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
2022
HER2 testing in gastric cancer diagnosis: Insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany.
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Stefanie Morris | 136 | 94 | 20 | 52 | 7 | 173 | |
| Zdenka Prodanovic | 119 | 53 | 13 | 59 | 8 | 214 | |
| Francesca Holt | 69 | 46 | 22 | 79 | 6 | 187 | |
| Xue‐Wu Wei | 167 | 160 | 13 | 53 | 13 | 258 | |
| Fabien Gaire | 130 | 53 | 47 | 38 | 10 | 195 | |
| Silvana Acquafredda | 151 | 90 | 18 | 38 | 8 | 223 | |
| David T. Hoang | 75 | 112 | 13 | 63 | 7 | 246 | |
| Nicolas Brandone | 175 | 152 | 15 | 41 | 8 | 244 | |
| G Sakamoto | 56 | 55 | 15 | 66 | 12 | 157 | |
| G. Lieberman | 147 | 85 | 43 | 40 | 9 | 229 | |
| Anna McLean | 80 | 65 | 11 | 58 | 5 | 193 |
All Works
Loading papers...